title: Tumor hypoxia is an important mechanism of radioresistance in hypofractionated radiotherapy and must be considered in the treatment planning process.
authors.affiliation: Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520-8040, USA. david.j.carlson@yale.edu
authors.forename: David J
authors.initials: DJ
authors.lastname: Carlson
authors.forename: Kamil M
authors.initials: KM
authors.lastname: Yenice
authors.forename: Colin G
authors.initials: CG
authors.lastname: Orton
mesh_terms: D019583:Dose Fractionation, Radiation; D006801:Humans; D008954:Models, Biological; D009369:Neoplasms / Q000503:physiopathology* / Q000532:radiotherapy*; D011836:Radiation Tolerance; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods*